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Background: Postural abnormalities in Parkinson’s disease (PD) form a spectrum of
functional trunk misalignment, ranging from a “typical” parkinsonian stooped posture to
progressively greater degrees of spine deviation.
Objective: To analyze the association between degree of postural abnormalities and
disability and to determine cut-off values of trunk bending associated with limitations in
activities of daily living (ADLs), motor impairment, falls, and back pain.
Methods: The study population was 283 PD patients with≥5◦ of forward trunk bending
(FTB), lateral trunk bending (LTB) or forward neck bending (FNB). The degrees were
calculated using a wall goniometer (WG) and software-based measurements (SBM).
Logistic regression models were used to identify the degree of bending associated with
moderate/severe limitation in ADLs (Movement Disorders Society Unified PD Rating
Scale [MDS-UPDRS] part II ≥17), moderate/severe motor impairment (MDS-UPDRS
part III ≥33), history of falls (≥1), and moderate/severe back pain intensity (numeric
rating scale≥4). The optimal cut-off was identified using receiver operating characteristic
(ROC) curves.
Results: We found significant associations between modified Hoehn & Yahr stage,
disease duration, sex, and limitation in ADLs, motor impairment, back pain intensity,
and history of falls. Degree of trunk bending was associated only with motor impairment
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in LTB (odds ratio [OR] 1.12; 95% confidence interval [CI], 1.03–1.22). ROC curves
showed that patients with LTB of 10.5◦ (SBM, AUC 0.626) may have moderate/severe
motor impairment.
Conclusions: The severity of trunkmisalignment does not fully explain limitation in ADLs,
motor impairment, falls, and back pain. Multiple factors possibly related to an aggressive
PD phenotype may account for disability in PD patients with FTB, LTB, and FNB.
Keywords: Parkinson’s disease, camptocormia, Pisa syndrome, anterocollis, postural abnormalities
INTRODUCTION
Postural abnormalities are common features of Parkinson’s
disease (PD) and manifest in over 20% of patients during the
course of disease (1). Three main types of PD-associated postural
abnormalities are distinguished: camptocormia (CC), defined as
an involuntary forward trunk bending (FTB) appearing during
standing or walking and resolving in a supine position of at least
30◦ at the lumbar fulcrum and/or at least 45◦ at the thoracic
fulcrum (2); Pisa syndrome (PS), defined as a sustained lateral
trunk bending (LTB) of at least 10◦ worsened by prolonged sitting
or walking (3); and anterocollis (AC), defined as an involuntary
forward neck bending (FNB) of at least 45◦ (3). PD studies
investigating CC, PS, and AC report greater disability in patients
with postural abnormalities and a higher risk of falls, back pain,
and worse quality of life (1, 3–6).
However, PD-associated postural abnormalities form a
spectrum of functional trunk misalignment, ranging from a
“typical” parkinsonian stooped posture, with rounding of the
shoulders and flexion of the hips and knees, to progressively
greater degrees of trunk bending. The current criteria for
the definition of CC, PS, and AC are mainly based on
expert opinion (3) or expert consensus (2), leaving issues
open on the classification of postural abnormalities not
fulfilling the criteria for CC, PS, or AC. Given the lack
of a common and comprehensive classification for postural
abnormalities and the still unexplored impact of “milder”
trunk flexion on disability, there is a rationale for revision
of the classification of PD-associated postural abnormalities:
(1) criteria for CC, PS, and AC have been decided a
priori based on observational judgment of movement disorder
experts and are not anchored to any formal measure of
activities of daily living (ADLs), motor impairment, risk of
falls or pain; and (2) the current cut-offs refer to very
severe conditions, leaving many PD patients with potentially
disabling postural abnormalities without an effective diagnosis of
postural abnormalities.
In this study, our primary aim was to analyze the
association between the degree of postural abnormalities
and disability, expressed as limitation in ADLs, motor
impairment, falls, and back pain. The secondary aim was
to determine the cut-off values of trunk/neck bending that
best predict the disability. We hypothesized that significant
disability in patients with postural abnormalities may not
be entirely related to the degrees of trunk bending and
that disability may occur at lower degrees of trunk bending
than the standard criteria for defining CC, PS, and AC,
which identify a final stage of a complex process of trunk
control impairment.
METHODS
For this study we retrieved data from a database created for
a multicenter epidemiological study on postural abnormalities
in PD, encompassing comprehensive information on 811
consecutive outpatients with PD attending seven tertiary
movement disorder centers in Italy (1).
Participants
The study population was patients with a diagnosis of
idiopathic PD (7) presenting ≥5◦ of FTB, LTB or FNB as
measured with a wall goniometer. Exclusion criteria were:
concomitant neurological diseases known to negatively affect
posture, previous major spinal surgery, skeletal, or muscle disease
(i.e., vertebral fractures, spondylodiscitis, and inflammatory
myopathy), and treatment with medications possibly causing
posture alterations (i.e., neuroleptics and antiemetics, except for
clozapine, quetiapine, and domperidone) in the 6 months prior
to enrollment.
The institutional review boards of the participating
centers reviewed and approved the study protocol. All
patients were informed about the nature of the study and
gave their written consent to participate. Authorization
was obtained for disclosure (consent-to-disclose) of any
recognizable persons in photographs. The study was registered
at https://clinicaltrials.gov (NCT03573232).
Procedures
At each center, patients were evaluated while on their usual
drug treatment during the ON phase. Postural evaluation was
performed with the use of a wall goniometer (WG) and
analysis of patients’ photographs during a single session by
the same rater assigned before the start of the study. The
following clinical and demographical features were recorded: age,
gender, age at PD onset, Movement Disorders Society Unified
Parkinson’s Disease Rating Scale (MDS-UPDRS) part I-IV to
assess PD severity (8), modified Hoehn & Yahr (H&Y) scale
to assess PD stage, disease duration (in years since diagnosis),
and PD phenotype (rigid-akinetic, tremor-dominant, or mixed
type) (9).
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Outcome Measures
Evaluation of Postural Abnormalities
Two instruments were used to measure FTB, LTB, and FNB.
The degree of trunk bending was calculated using the WG
(2, 10, 11) and software-based measurements (SBM) with
the freeware program Kinovea R© (10, 12). Patients with FTB
were subdivided into a lower and an upper FTB angle group
according to the fulcrum level (2). For the WG measures, a
rater trained at each center rated the angles independently.
For SBM, an experienced rater (C.G.) was trained in the
use of the freeware program Kinovea R© and performed all
measurements on the patients’ photographs. Interobserver
reliability between the two raters in the use of WG and software-
based measurement to measure FTB, LTB, and FNB is good to
excellent (10).
The WG was used to visually estimate the degree of
bending in patients while standing or sitting (10, 11). The
zero of WG was positioned at the level of the fulcrum. A line
perpendicular to the ground and an imaginary line drawn from
the fulcrum of bending through the C7 spinal process (or the
tragus of the ear for the FNB) formed the outer angle. The
minimal detectable change for the WG recorded in degrees
was 5◦.
All patients underwent evaluation also with SBM. The lower
FTB angle was calculated on the sagittal view photographs using
the software-based malleolus method. A line was drawn from
the L5 end of the L5/C7 line to the lateral malleolus of the foot,
the external angle between these lines was measured (Figure 1A)
(10, 13). The upper FTB angle was calculated on the sagittal view
photographs as the outer angle between the two lines fulcrum-
L5 and fulcrum-C7, with the fulcrum defined as the most distant
point perpendicular to the L5/C7 line (Figure 1B) (10, 12). The
LTB angle was calculated on the planar view photographs as the
angle between (a) the vertical axis and (b) a line connecting
the fulcrum of the bent spine with the C7 spinous process
(Figure 1C) (14). The FNB was calculated on the sagittal view
photographs as the angle between (a) a line connecting the
C7 spinous process and the tragus of the ear, and (b) the line
perpendicular to the ground (Figure 1D) (15).
Evaluation of Limitation in ADLs, Motor Impairment,
Falls, and Pain
Limitation in ADLs was evaluated according to theMDS-UPDRS
part II score (8) and motor impairment by the MDS-UPDRS part
III score (8). According to the literature, an MDS-UPDRS part II
score ≥17 identifies moderate/severe limitation in ADLs (16, 17)
and an MDS-UPDRS part III score ≥33 moderate/severe motor
TABLE 1 | Clinical Features of PD Patients with one or more postural abnormality
of forward trunk bending, lateral trunk bending, and forward neck bending.
Variables Patients with one or more PA
FTB LTB FNB
No. of patients 215 88 61
Age, mean (SD), y 73.50 (8.1) 73.23 (7) 70.97 (7.8)
Gender, No. (%),
Male 134 (62.3) 51 (58) 43 (70.5)
Female 81 (37.7) 37 (42) 18 (29.5)
Age at PD onset, mean (SD), y 65.05 (9.8) 62.69 (10.5) 61.3 (10.3)
UPDRS Total score on state,
mean (SD)
56.9 (24.6) 58.02 (27.7) 62.8 (29.1)
I 7.7 (6.4) 7.33 (6.5) 8.8 (6.7)
II 15.3 (7.9) 17.7 (8.9) 15.6 (9.3)
III 31.8 (13.4) 30.3 (14) 36 (15.7)
IV 2 (2.93) 2.7 (3.7) 2.1 (2.8)
Modified H&Y stage, mean
(SD)
2.62 (0.8) 3.09 (0.9) 2.5 (0.9)
Disease Duration, mean (SD), y 8.02 (5.9) 10.22 (7.1) 9.5 (7.6)
Dominant Phenotype, n (%)
Bradykinetic/Rigid type 106 (49.3) 47 (53.4) 26 (42.6)
Tremor type 33 (15.4) 20 (22.7) 18 (29.5)
Mixed Type 76 (35.3) 21 (23.9) 17 (27.9)
L-dopa equivalent daily dose,
mg, mean
(SD)
632.27 (349.54) 666.43 (339.76) 581.13 (330.23)
SD, standard deviation; PD, Parkinson’s Disease; PA, Postural Abnormalities including
forward trunk bending (FTB), lateral trunk bending (LTB), and forward neck bending (FNB);
y, years; H&Y, Hoehn and Yahr; UPDRS, Unified Parkinson’s Disease Rating Scale.
FIGURE 1 | (A) The malleolus method; (B) the upper method; (C,D) the perpendicular method.
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impairment (18). Patients were categorized as “fallers” if they
reported having sustained at least one fall in the previous month
(19). A numeric rating scale (NRS) graded from 0 (no pain at
all) to 10 (excruciating pain) was used to rate back pain intensity
(20). A score ≥4 identified moderate/severe pain because it can
interfere with the quality of life (21, 22).
Statistical Analysis
Descriptive statistics included frequency tables and calculation of
means and standard deviation (SD) for each group of patients
(FTB, LTB, and FNB). In patients with combined upper and lower
FTB, we used the upper fulcrum degrees as upper FTB and the
lower fulcrum degrees as lower FTB.
Logistic regression models were used to estimate unadjusted
and adjusted odds ratios (95% confidence interval [CI]) of
MDS-UPDRS parts II, III, history of falls, NRS (dependent
variables) in relation to the degree of trunk bending
(independent variable); adjustment was performed taking
into account the following sociodemographic and clinical
features as covariates: gender, modified H&Y stage, and disease
duration. Variables having clinical relevance (1) or p < 0.05
at univariate analysis were entered in the multivariate analysis
as covariates.
When an association between the dependent variable and the
degree of bending was found, sensitivity and specificity were
calculated. Receiver operating characteristic (ROC) curves were
constructed and the Youden index (the highest sum of values of
sensitivity and specificity minus one) was calculated to obtain
the optimal cut-off values of the degree of bending to identify
patients with impairment. Areas under the curve (AUC) of
the ROC curves were calculated to provide a measure of the
overall discriminative ability of the prediction rule. Typically,
a test with an AUC > 0.9 has high accuracy, while an AUC
0.7–0.9 indicates moderate accuracy, 0.5–0.7 low accuracy, and
0.5 is compared to toss-up (chance result) (23). All tests were
two-tailed and considered a p-value < 0.05 as statistically
significant. Data were analyzed using the Statistical Package
for the Social Sciences (SPSS 22 for Mac, IBM-SPSS, Armonk,
NY, USA).
RESULTS
Clinical Features of Patients
A total of 283 PD patients were enrolled according to the
inclusion and exclusion criteria. A total of 215 patients presented
FTB (175 upper type, 27 lower type, and 13 both types), 88
TABLE 2 | Clinical and demographic variables associated with upper FTB, as measured with a wall goniometer.
Dependent variable Independent variables Total* sample Unadjusted Adjusted
OR 95% CI P-value OR 95% CI P-value
Limitations in ADLs
Number of patients 188
Sex, males vs. females∧ 0.99 0.5–.84 0.98 1.76 0.8–.82 0.15
Modified H&Y stage 5.01 2.99–8.38 <0.0005 4.34 2.47–7.61 <0.0005
Disease duration, y 1.15 1.08–1.23 <0.0005 1.08 1.00–1.17 0.049
Degrees 1.06 1.02–1.09 0.001 1.02 0.98–1.06 0.38
Motor impairment
Number of patients 188
Sex, males vs. females∧ 1.14 0.62–2.10 0.67 1.56 0.80–3.02 0.19
Modified H&Y stage 2.13 1.44–3.15 <0.0005 2.43 1.53–3.85 <0.0005
Disease duration, y 1.02 0.97–1.07 0.46 0.96 0.91–1.03 0.27
Degrees 1.02 0.99- 1.06 0.13 1.01 0.97–1.04 0.64
Back pain
Number of patients 188
Sex, males vs. females∧ 0.67 0.36–1.24 0.20 0.78 0.41–1.49 0.47
Modified H&Y stage 1.81 1.24–2.64 0.002 1.63 1.06–2.49 0.026
Disease duration, y 1.05 0.99–1.11 0.06 1.02 0.96–1.08 0.49
Degrees 1.02 0.99–1.06 0.14 1.00 0.97–1.04 0.73
Falls
Number of patients 188
Sex, males vs. females∧ 1.16 0.57–2.34 0.68 1.43 0.68–2.99 0.34
Modified H&Y stage 1.77 1.17–2.67 0.006 2.06 1.27–3.32 0.003
Disease duration, y 1.02 0.96–1.07 0.58 0.98 0.92–1.05 0.61
Degrees 1 0.96–1.04 0.97 0.98 0.94–1.02 0.41
CI, confidence interval; H&Y, Hoehn and Yahr; OR, Odds Ratio; PAD, Parkinson disease; ∧, denotes the reference category; FTB, forward trunk bending; *The total sample included the
isolated upper FTB (n = 175) and combined forms (upper + lower FTB, n = 13); significant associations in bold at p < 0.05.
Frontiers in Neurology | www.frontiersin.org 4 March 2020 | Volume 11 | Article 207
Geroin et al. Postural Abnormalities and Disability in PD
TABLE 3 | Clinical and demographic variables associated with lower FTB, as measured with a wall goniometer.
Dependent variable Independent variables Total sample* Unadjusted Adjusted
OR 95% CI P-value OR 95% CI P-value
Limitations in ADLs
Number of patients 40
Sex, males vs. females∧ 0.60 0.17–2.16 0.43 0.77 0.17–3.56 0.74
Modified H&Y stage 5.32 1.67–16.93 0.005 6.54 1.79–23.78 0.004
Disease duration, y 0.97 0.88–1.07 0.57 0.92 0.81–1.05 0.21
Degrees 1.01 0.95–1.07 0.71 1 0.94–1.07 0.94
Motor impairment
Number of patients 40
Sex, males vs. females∧ 0.86 0.25–3.05 0.82 1.61 0.33–7.77 0.55
Modified H&Y stage 4.64 1.57–13.74 0.006 6.03 1.67–21.67 0.006
Disease duration, y 0.98 0.89–1.08 0.78 0.96 0.85–1.09 0.57
Degrees 1.05 0.98–1.11 0.17 1.06 0.97–1.15 0.16
Back pain
Number of patients 40
Sex, males vs. females∧ 2.09 0.52–8.46 0.30 1.65 0.36–7.64 0.52
Modified H&Y stage 0.62 0.26–1.45 0.27 0.66 0.26–1.67 0.38
Disease duration, y 0.98 0.89–1.08 0.70 0.95 0.85–1.06 0.36
Degrees 0.94 0.88–1 0.06 0.93 0.87–1 0.06
Falls
Number of patients 40
Sex, males vs. females∧ 2.22 0.62–7.98 0.22 3.74 0.85–16.51 0.08
Modified H&Y stage 1.70 0.76–3.81 0.19 2.15 0.84–5.46 0.11
Disease duration, y 0.96 0.88–1.06 0.48 0.97 0.87–1.08 0.59
Degrees 1.04 0.98–1.11 0.18 1.05 0.98–1.13 0.17
CI, confidence interval; H&Y, Hoehn and Yahr; OR, Odds Ratio; PAD, Parkinson disease; ∧, denote the reference category; FTB, forward trunk bending; *The total sample included the
isolated lower FTB (n = 27) and combined forms (upper + lower FTB, n = 13); significant associations in bold at p < 0.05.
LTB and 61 FNB. Upper FTB ranged from 21.3◦ to 72.3◦
[mean and standard deviation SBM 44.8 ± 8.6, WG 41.9◦
± 8.9◦]. Lower FTB ranged from 5◦ to 60◦ (SBM 28.9◦ ±
10.6◦, WG 25.2◦ ± 12.4◦). Coexistent upper/lower subtype
ranged from 20◦ to 60◦ (SBM upper 40.7◦ ± 10.1◦, WG
45.8◦ ± 11.7◦; SBM lower 31.7◦ ± 9.2◦, WG 28.1◦ ± 8.8◦).
LTB ranged from 5◦ to 45◦ (SBM 11.3◦ ± 7.4◦, WG 11.7◦
± 7.4◦). FNB ranged from 15◦ to 106.2◦ (SBM 62.5◦ ±
20◦, WG 58.7◦ ± 20.4◦). Table 1 presents the clinical and
demographical features.
Correlation of Clinical and Demographical
Variables With Limitation in ADLs, Motor
Impairment, Falls, and Pain
In the measures taken with the WG, the univariate logistic
regression model yielded significant associations between
upper/lower FTB, LTB, and FNB and many of the investigated
clinical and demographic features (Tables 2–5). After adjusting
for all variables in the model, multivariate logistic regression
analysis confirmed the following associations.
Upper FTB: modified H&Y stage (OR 4.34, 95% CI 2.47–7.61)
and disease duration (OR 1.08, 95%CI 1–1.17) were associated
with limitations in ADLs. The modified H&Y stage was also
associated with motor impairment (OR 2.43, 95% CI 1.53–
3.85), back pain (OR 1.63, 95% CI 1.06–2.49), and falls (OR
2.06, 95% CI 1.27–3.32) (Table 2).
Lower FTB: modified H&Y stage was associated with
limitations in ADLs (OR 6.54, 95% CI 1.79–23.78) and motor
impairment (OR 6.03, 95% CI 1.67–21.67) (Table 3).
LTB: modified H&Y stage (OR 4.26, 95% CI 2.07–8.77) was
associated with limitations in ADLs. Sex (OR 0.35, 95% CI
0.12–0.99), modified H&Y stage (OR 2.75, 95% CI 1.33–5.58),
and degree of trunk bending (OR 1.12, 95%CI 1.03–1.22) were
associated withmotor impairment. Sex (OR 0.33, 95%CI 0.13–
0.87) and modified H&Y stage (OR 1.86, 95% CI 1.01–3.41)
were associated with back pain (Table 4).
FNB: modified H&Y stage (OR 3.37, 95% CI 1.33–8.53) was
associated with motor impairment (Table 5).
The SBM showed similar results in the adjusted and unadjusted
ORs. No other statistically significant value was found for
upper/lower FTB, LTB, and FNB measured with the WG and
SBM (Tables 2–5 and Supplementary Tables 1–4).
ROC Curve Analysis
Given the significant association in the multivariate logistic
regression model, we performed ROC analysis to predict the
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TABLE 4 | Clinical and demographic variables associated with LTB, as measured with a wall goniometer.
Dependent variable Independent variables Total sample Unadjusted Adjusted
OR 95% CI P-value OR 95% CI P-value
Limitations in ADLs
Number of patients 88
Sex, males vs. females∧ 1.08 0.46–2.56 0.85 0.72 0.23–2.23 0.57
Modified H&Y stage 4.66 2.46–8.82 <0.0005 4.26 2.07–8.77 <0.0005
Disease duration, y 1.17 1.07–1.28 0.001 1.09 0.98–1.22 0.08
Degrees 1.02 0.96–1.08 0.46 1.08 0.99–1.17 0.07
Motor impairment
Number of patients 88
Sex, males vs. females∧ 0.54 0.22–1.29 0.16 0.35 0.12–0.99 0.049
Modified H&Y stage 2.14 1.24–3.70 0.006 2.75 1.33–5.58 0.005
Disease duration, y 1.06 0.99–1.13 0.07 1.02 0.95–1.10 0.56
Degrees 1.06 0.99–1.13 0.06 1.12 1.03–1.22 0.007
Back pain
Number of patients 88
Sex, males vs. females∧ 0.41 0.16–0.99 0.049 0.33 0.13–0.87 0.024
Modified H&Y stage 1.53 0.94–2.94 0.08 1.86 1.01–3.41 0.046
Disease duration, y 1.02 0.96–1.08 0.56 0.98 0.92–1.06 0.74
Degrees 1.03 0.97–1.09 0.38 1.05 0.98–1.13 0.15
Falls
Number of patients 88
Sex, males vs. females∧ 1.56 0.60–4.02 0.36 1.45 0.54–3.92 0.46
Modified H&Y stage 1.61 0.93–2.79 0.09 1.82 0.96–3.44 0.07
Disease duration, y 1.02 0.95–1.08 0.59 0.99 0.92–1.07 0.84
Degrees 1.05 0.98–1.11 0.13 1.06 0.99–1.13 0.08
CI, confidence interval; H&Y, Hoehn and Yahr; OR, Odds Ratio; LTB, Lateral Trunk Bending; ∧, denotes the reference category; significant associations in bold at p < 0.05.
LTB cut-off angle for best discriminating low vs. high disability.
According to the clinical WG evaluation, the optimal cut-off
value was 12.5◦, with a sensitivity of 0.5 and a specificity of 0.8
(AUC 0.615; p: 0.071). According to the SBM, the optimal cut-off
value was 10.5◦, with a sensitivity of 0.5 and a specificity of 0.8
(AUC 0.626; p: 0.048).
DISCUSSION
With this study we wanted to analyze the influence of trunk
bending severity on disability and determine the cut-off values
of trunk bending that best discriminated limitations in ADLs,
motor impairment, falls, and back pain. The adjusted odds ratios
showed a significant association between motor impairment and
degree of LTB, indicating that an increase in lateral bending
increases the probability of greater motor impairment. We found
that the optimal cut-off to identify moderate to severe motor
impairment was 10.5◦, corresponding to the most common cut-
off for the diagnosis of PS (3, 11). In contrast, for upper/lower
FTB and FNB we found no association between limitation of
ADLs, motor impairment, pain, and falls and the degree of
bending, except for a more advanced stage of disease (H&Y
stage), longer disease duration, and sex. Our data cannot explain
the association between the degree of LTB and female gender
with motor impairment. However, we hypothesize that trunk
asymmetry related to LTB may reduce trunk mobility more than
FTB, leading to a greater impairment in motor functions, and
intrinsic gender differences of the anatomy of the spine (24)
may be a predisposing factor, along with subclinical osteoporosis
for which the frequency in women is more than double that in
men (25).
PD-associated postural abnormalities have attracted
increasing attention from clinicians and researchers since
they were recognized as a frequent and disabling complication
of PD (1, 3–6, 26). Most studies on severe forward and lateral
trunk flexion (i.e., CC, PS, and AC) to date have applied arbitrary
and often diverse diagnostic criteria (2, 3). Despite the different
criteria employed, greater disability is noted in patients with CC,
PS, and AC than in those without severe postural abnormalities
(1). Moreover, patients with lower CC seem to have more severe
gait and postural control impairment than those with upper CC
and without CC (26). Our data show that the severity of trunk
bending cannot fully explain impairments. Patients with a more
advanced PD stage and longer disease duration are at higher risk
of having limitations in ADLs, motor impairment, back pain, and
falls, independent of the degree of trunk bending. Our data are
consistent with previous studies indicating that the association
between postural abnormalities and such variables may be more
closely related to the severity of the PD phenotype and disease
progression than to the severity of trunk flexion itself (1, 5).
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TABLE 5 | Clinical and demographic variables associated with FNB, as measured with a wall goniometer.
Dependent variable Independent variables Total sample Unadjusted Adjusted
OR 95% CI P-value OR 95% CI P-value
Limitations in ADLs
Number of patients 61
Sex, males vs. females∧ 0.93 0.30–2.88 0.90 1.27 0.26–6.18 0.77
Modified H&Y stage 3.98 1.92–8.23 <0.0005 2.32 0.97–5.50 0.06
Disease duration, y 1.21 1.08–1.35 0.001 1.12 0.99–1.27 0.07
Degrees 1.03 1–1.06 0.027 1.02 0.98–1.05 0.32
Motor impairment
Number of patients 61
Sex, males vs. females∧ 0.73 0.24–2.25 0.58 0.93 0.24–3.54 0.91
Modified H&Y stage 2.60 1.33–5.10 0.005 3.37 1.33–8.53 0.010
Disease duration, y 1.06 0.98–1.14 0.16 0.96 0.86–1.07 0.50
Degrees 1 0.98–1.03 0.85 0.99 0.96–1.02 0.57
Back pain
Number of patients 61
Sex, males vs. females∧ 1.87 0.56–6.19 0.30 1.76 0.46–6.73 0.41
Modified H&Y stage 1.29 0.74–2.25 0.36 2.16 0.93–5.02 0.07
Disease duration, y 0.97 0.90–1.04 0.42 0.91 0.81–1.01 0.08
Degrees 1.01 0.98–1.04 0.33 1.01 0.98–1.04 0.57
Falls
Number of patients 61
Sex, males vs. females∧ 2.68 0.67–10.74 0.16 4.69 0.98–22.35 0.05
Modified H&Y stage 1.04 0.57–1.86 0.90 0.85 0.35–2.07 0.72
Disease duration, y 1.03 0.96–1.10 0.41 1.07 0.96–1.20 0.18
Degrees 0.98 0.96–1.02 0.39 0.97 0.94–1.01 0.11
CI, confidence interval; H&Y, Hoehn and Yahr; OR, Odds Ratio; FNB, Forward Neck Bending; ∧, denotes the reference category; y, years; significant associations in bold at p < 0.05.
With regard to limitations in ADLs and perceived pain, a study
uncorrected for possible confounders involving 145 subjects with
PD and FTB did not yield convincing evidence for a threshold
angle defining CC (27). Indeed, while showing a significant
association between FTB≥30◦ and limitations in ADLs and back
pain, the authors remarked that less severe forward angles do
not exclude CC (27). They found greater limitations in ADLs
in patients with FTB ≥30◦, which is in line with our univariate
regression models reported for upper FTB. Nevertheless, here
we demonstrate that this association did not survive multivariate
logistic regression analysis, which indicated that sex, duration
and stage of disease are relevant confounding factors.
Pain, one of the most frequent non-motor symptoms of PD,
has been strongly associated with a worse quality of life (28–
30). The relationship between PD and pain is complex and
not fully elucidated; however, it has been demonstrated that
PD patients with motor complications have a greater risk of
developing pain (31), which seems to increase with worsening
parkinsonian symptoms (28). Our findings suggest that the
back pain in patients with trunk misalignment could be more
closely related to the PD stage and duration than to the
postural alterations.
Hence, the severity of trunk/neck bending alone does not
explain limitation in ADLs, motor impairment, falls, and back
pain in PD patients. Multiple factors possibly related to an
aggressive PD phenotype account for disability. Nonetheless,
less severe degrees of trunk bending—though not classified
as CC, PS, or AC—should be monitored (i.e., quantitively by
using apps) (32) and promptly treated (i.e., physiotherapy)
(33) to prevent progression and worsening and to avoid
permanent deformity. Physiotherapy should include active self-
correction, trunk stabilization exercises (i.e., strengthening of
compensatory paraspinal muscles) and functional tasks, along
with pharmacological intervention such as botulinum toxin
injection to reduce muscle hyperactivity (4, 14, 33, 34).
Some limitations should be taken into account when
interpreting our results. First, the ROC analysis showed only a
moderate accuracy of discrimination, as reflected by AUC values
and the not very high values of sensitivity and specificity. Second,
the necessity of a dichotomous outcome to run the ROC analysis
required us to identify validated cut-offs for the patient-centered
outcome measures. We could not find such cut-off values for
Parkinson’s disease Questionnaire 8, which would have extended
the analysis to include quality of life. Third, the history of falls
was based on patient-reported number of falls in the month
before assessment, and no significant FTB, LTB, or FNB values
were found for discriminating the history of falls. It is possible
that analysis with more accurate recording of falls might have
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yielded significant results. Fourth, we did not evaluate as specific
outcomesmotor fluctuations, cognitive impairment, and freezing
of gait which can be present in patients with PD and postural
abnormalities (35) and associated with poor quality of life and
falls. Finally, a prospective study design would help clarify the
association and risk factors for disability in a cohort of patients
with postural abnormalities.
These limitations notwithstanding, our findings indicate that
advanced stage of disease and longer disease duration, but
not the degree of trunk bending, may explain the greater
disability of PD patients with postural abnormalities. Limitation
in ADLs and presence history of falls and severe pain in FTB,
LTB, and FNB may be more closely related to PD phenotype
and progression than trunk flexion itself (1, 5). In contrast,
moderate/severe motor impairment can be predicted by a degree
of LTB > 10◦, which is the cut-off typically used for the
diagnosis of PS. This is an important finding because it justifies
the widely used cut-off of 10◦ defined a priori by previous
studies. Summarizing, all patients with PS should be referred
to management by a multidisciplinary team at an early stage
to improve their quality of life and slow the progress of motor
decline (4).
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